LDS Hospital, Salt Lake City, Utah Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00334464
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

LDS Hospital Cardiovascular Research

Active Ingredients

Drugs in Phase 2 Trials (2)

darbepoetin alfa (aranesp) (1 trial)

epoetin (Epogen) (1 trial)

Drugs in Other Trials (1)

warfarin (coumadin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3